IDL has signed a new distribution agreement in Uganda Read the press release here
IDL signs distribution agreement in Uganda
read more
News
Financial News
Meta analysis on TUBEX
Achieving accurate laboratory diagnosis of typhoid fever: a review and meta-analysis of TUBEX® TF clinical performance. Read the article here: Read the press release here:
IDL signed two new distributions agreements
IDL has signed two new distributions agreements. Please read the press release here (Asia) and here (Kenya)
IDL Biotech AB continues preparations to introduce its rapid test for bladder cancer, UBC Rapid, in the US.
IDL Biotech has started the work on mapping the US market. Read more here
IDL Biotech launches TUBEX TF in Kenya
On September 17, 2019, IDL Biotech will launch the company's rapid test for typhoid fever, TUBEX TF, in Kenya. Read more here
